Unlicensed cord blood units tested for safety in blood cancer patients

NCT ID NCT01451502

Recruiting now Disease control Sponsor: Masonic Cancer Center, University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing the safety of using unlicensed umbilical cord blood units for transplants in people with blood cancers or lymphatic diseases. Researchers will monitor for infections and serious reactions after infusion. The goal is to see if these unlicensed units can be a safe option when licensed units are not the best match.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord blood cells
What this could lead to: If successful, this could expand access to cord blood transplants for patients with blood cancers or immune disorders when licensed units are not available.
What could go wrong: This is an early safety study, not testing effectiveness. Risks include infection transmission and infusion reactions. The unlicensed units may not work as well as licensed ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm lymphatic system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC MALIGNANCY LYMPHATIC DISEASES

Contacts and locations

Locations

Masonic Cancer Center, University of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.